Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001101669.3(INPP4B):c.2350T>G(p.Phe784Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
INPP4B (HGNC:6075): (inositol polyphosphate-4-phosphatase type II B) INPP4B encodes the inositol polyphosphate 4-phosphatase type II, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate. There is limited data to suggest that the human type II enzyme is subject to alternative splicing, as has been established for the type I enzyme. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.2350T>G (p.F784V) alteration is located in exon 24 (coding exon 20) of the INPP4B gene. This alteration results from a T to G substitution at nucleotide position 2350, causing the phenylalanine (F) at amino acid position 784 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);.;Gain of catalytic residue at F784 (P = 0.0208);.;